Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

JOURNAL ARTICLE

ACG Clinical Guideline: Primary Sclerosing Cholangitis

Keith D Lindor, Kris V Kowdley, M Edwyn Harrison

American Journal of Gastroenterology 2015, 110 (5): 646-59; quiz 660

Primary sclerosing cholangitis is a chronic cholestatic liver disease that can shorten life and may require liver transplantation. The cause is unknown, although it is commonly associated with colitis. There is no approved or proven therapy, although ursodeoxycholic acid is used by many on an empiric basis. Complications including portal hypertension, fat-soluble vitamin deficiency, metabolic bone diseases, and development of cancers of the bile duct or colon can occur.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Responses

Sort by: Most Recent • Highest Rated

Joseph Martin

What is the median life expectancy of patients with PSC?

What are the criteria for liver transplant and what percentage of pts. require it?

Posted 23 Jan, 2016 at 23:08

-1

Related Papers

Bile acids for primary sclerosing cholangitis. Goran Poropat, Vanja Giljaca, Davor Stimac, Christian Gluud Cochrane Database of Systematic Reviews 2011, (1): CD003626

Primary sclerosing cholangitis. Mariben R Geonzon-Gonzales Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 2007, 30 (2): 102-5; quiz 105-7

Primary Sclerosing Cholangitis. Young-Mee Lee, David J. Kim Current Treatment Options in Gastroenterology 2001, 4 (6): 469-477

[Primary sclerosing cholangitis--diagnosis and therapy]. Lucija Virović, Vladimir Supanc, Marko Duvnjak Acta Medica Croatica: C̆asopis Hravatske Akademije Medicinskih Znanosti 2003, 57 (3): 207-19

Sclerosing cholangitis. George R MacFaul, Roger W Chapman Current Opinion in Gastroenterology 2006, 22 (3): 288-93

Sclerosing cholangitis. George R MacFaul, Roger W Chapman Current Opinion in Gastroenterology 2005, 21 (3): 348-53

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. A Stiehl, S Walker, L Stiehl, G Rudolph, W J Hofmann, L Theilmann Journal of Hepatology 1994, 20 (1): 57-64

Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection? J E Hay Liver Transplantation and Surgery 1998, 4 (5): S9-17

Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. J A Goss, C R Shackleton, D G Farmer, W S Arnaout, P Seu, J S Markowitz, P Martin, R J Stribling, L I Goldstein, R W Busuttil Annals of Surgery 1997, 225 (5): 472-81; discussion 481-3

Proctocolectomy for ulcerative colitis after liver transplantation for primary sclerosing cholangitis. M C Bosso, P E Marchesa, A Ricchiuti, A Giacardi, D Cocchis, M Campi, M Palisi, M Salizzoni Transplantation Proceedings 2009, 41 (4): 1390-2

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

ACG Clinical Guideline: Primary Sclerosing Cholangitis

Discussion

Responses

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips